Cancer Communications
indexed by SCI
BMC


Original article
Safety and efficacy of obinutuzumab in Chinese patients with B-cell lymphomas: a secondary analysis of the GERSHWIN trial
Yan Qin, Yuqin Song, Zhixiang Shen, Xin Du, Wei Ji, Wanling Hsu, Jun Zhu and Yuankai Shi
[ [Abstract ]    [ Abstract  489]    [ PDF Full-text  344]    [ PubMed]   Epub: 5/30/2018   doi:10.1186/s40880-018-0300-5
Case report
Spontaneous regression of mantle cell lymphoma: a report of four cases
Haige Ye, Aakash Desai, Tiejun Gong, Dongfeng Zeng, Krystle Nomie, Wendy Chen, Wei Wang, Jorge Romaguera and Michael L. Wang
[ [Abstract ]    [ Abstract  515]    [ PDF Full-text  364]    [ PubMed]   Epub: 5/30/2018   doi:10.1186/s40880-018-0306-z
Original article
Long- versus short-interval follow-up after resection of hepatocellular carcinoma: a retrospective cohort study
Wei He, Yun Zheng, Ruhai Zou, Jingxian Shen, Junping Yang, Jiliang Qiu, Qiang Tao, Wenwu Liu, Zhiwen Yang, Yuanping Zhang, Binkui Li and Yunfei Yuan
[ [Abstract ]    [ Abstract  581]    [ PDF Full-text  394]    [ PubMed]   Epub: 5/30/2018   doi:10.1186/s40880-018-0296-x
Original article
Epidermal growth factor receptor (EGFR) T790M mutation identified in plasma indicates failure sites and predicts clinical prognosis in non-small cell lung cancer progression during first-generation tyrosine kinase inhibitor therapy: a prospective observational study
Shirong Zhang, Lucheng Zhu, Bing Xia, Enguo Chen, Qiong Zhao, Xiaochen Zhang, Xueqin Chen, Xufeng Chen and Shenglin Ma
[ [Abstract ]    [ Abstract  539]    [ PDF Full-text  397]    [ PubMed]   Epub: 5/22/2018   doi:10.1186/s40880-018-0303-2
Review
Lipid metabolism reprogramming and its potential targets in cancer
Chunming Cheng, Feng Geng, Xiang Cheng and Deliang Guo
[ [Abstract ]    [ Abstract  516]    [ PDF Full-text  362]    [ PubMed]   Epub: 5/21/2018   doi:10.1186/s40880-018-0301-4
Review
Metabolic recoding of epigenetics in cancer
Yi-Ping Wang and Qun-Ying Lei
[ [Abstract ]    [ Abstract  545]    [ PDF Full-text  412]    [ PubMed]   Epub: 5/21/2018   doi:10.1186/s40880-018-0302-3
Original article
Neoadjuvant oxaliplatin and capecitabine combined with bevacizumab plus radiotherapy for locally advanced rectal cancer: results of a single-institute phase II study
Xin Yu, Qiao-xuan Wang, Wei-wei Xiao, Hui Chang, Zhi-fan Zeng, Zhen-hai Lu, Xiao-jun Wu, Gong Chen, Zhi-zhong Pan, De-sen Wan, Pei-rong Ding and Yuan-hong Gao
[ [Abstract ]    [ Abstract  539]    [ PDF Full-text  365]    [ PubMed]   Epub: 5/21/2018   doi:10.1186/s40880-018-0294-z
Original article
A novel nomogram individually predicting disease-specific survival after D2 gastrectomy for advanced gastric cancer
Wei Wang, Zhe Sun, Jing-Yu Deng, Xiao-Long Qi, Xing-Yu Feng, Cheng Fang, Xing-Hua Ma, Zhen-Ning Wang, Han Liang, Hui-Mian Xu and Zhi-Wei Zhou
[ [Abstract ]    [ Abstract  475]    [ PDF Full-text  382]    [ PubMed]   Epub: 5/15/2018   doi:10.1186/s40880-018-0293-0
Original article
Cardiotoxicity of 5-fluorouracil and capecitabine in Chinese patients: a prospective study
Jianjun Peng, Chao Dong, Chang Wang, Weihua Li, Hao Yu, Min Zhang, Qun Zhao, Bo Zhu, Jun Zhang, Wenliang Li, Fenghua Wang, Qiong Wu, Wenhao Zhou, Ying Yuan, Meng Qiu and Gong Chen
[ [Abstract ]    [ Abstract  493]    [ PDF Full-text  357]    [ PubMed]   Epub: 5/11/2018   doi:10.1186/s40880-018-0292-1
Original Article
Effect of induction chemotherapy with cisplatin, fluorouracil, with or without taxane on locoregionally advanced nasopharyngeal carcinoma: a retrospective, propensity score-matched analysis
Guo-Ying Liu, Xing Lv, Yi-Shan Wu, Min-Jie Mao, Yan-Fang Ye, Ya-Hui Yu, Hu Liang, Jing Yang, Liang-Ru Ke, Wen-Ze Qiu, Xin-Jun Huang, Wang-Zhong Li, Xiang Guo, Yan-Qun Xiang and Wei-Xiong Xia
[ [Abstract ]    [ Abstract  323]    [ PDF Full-text  363]    [ PubMed]   Epub: 5/10/2018   doi:10.1186/s40880-018-0283-2

<<    Page 70 of 81  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China